TATVA

Tatva Chintan Pharma Chem Share Price

₹987.15
+ 19.7 (2.04%)
  • Advice
  • Hold
20 September, 2024 18:29 BSE: 543321 NSE: TATVA ISIN: INE0GK401011

Start SIP in Tatva Chintan Pharma Chem

Start SIP

Tatva Chintan Pharma Chem Performance

Day Range

  • Low 968
  • High 991
₹ 987

52 Week Range

  • Low 932
  • High 1,651
₹ 987
  • Open Price975
  • Previous Close967
  • Volume45817

Tatva Chintan Pharma Chem Chart

  • Over 1 Month + 0.93%
  • Over 3 Month -9.32%
  • Over 6 Month -15.35%
  • Over 1 Year -39.82%

Tatva Chintan Pharma Chem Key Statistics

P/E Ratio 88.6
PEG Ratio -2.1
Market Cap Cr
Price to Book Ratio 3.1
EPS 12.6
Dividend 0.2
Relative Strength Index 50.2
Money Flow Index 49.26
MACD Signal -10.28
Average True Range 28.63

Tatva Chintan Pharma Chem Investment Rating

  • Master Rating:
  • Tatva Chintan Pharma Chem has an operating revenue of Rs. 384.61 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 11% is healthy, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 3 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 116 indicates it belongs to a poor industry group of Chemicals-Basic and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Tatva Chintan Pharma Chem Financials
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 94948693106119
Operating Expenses Qtr Cr 8680747286104
Operating Profit Qtr Cr 81412212015
Depreciation Qtr Cr 767763
Interest Qtr Cr 000333
Tax Qtr Cr 14243-9
Net Profit Qtr Cr 2858816
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 386409
Operating Expenses Annual Cr 312348
Operating Profit Annual in Cr 6755
Depreciation Cr 2610
Interest Annual Cr 78
Tax Annual Cr 13-2
Net Profit Annual Cr 2940
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 10324
Cash from Investing Activity Annual Cr -121-101
Cash from Financing Annual Activity Cr 3138
Net Cash Flow Annual Cr 13-40
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 726505
Fixed Assets Annual Cr 503427
Total Non Current Assets Annual Cr 521443
Total Current Assets Annual Cr 294311
Total Assets Annual Cr 815755
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 310228
ROE Annual % 48
ROCE Annual % 710
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 2015
IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 105988497114125
Operating Expenses Qtr Cr 9383737693108
Operating Profit Qtr Cr 131611202116
Depreciation Qtr Cr 767763
Interest Qtr Cr 000333
Tax Qtr Cr 24234-9
Net Profit Qtr Cr 510381017
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 401429
Operating Expenses Annual Cr 325363
Operating Profit Annual in Cr 6861
Depreciation Cr 2610
Interest Annual Cr 78
Tax Annual Cr 13-1
Net Profit Annual Cr 3045
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr 9828
Cash from Investing Activity Annual Cr -121-101
Cash from Financing Annual Activity Cr 3138
Net Cash Flow Annual Cr 8-36
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 737515
Fixed Assets Annual Cr 503427
Total Non Current Assets Annual Cr 521443
Total Current Assets Annual Cr 298314
Total Assets Annual Cr 819756
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 315232
ROE Annual % 49
ROCE Annual % 711
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1916

Tatva Chintan Pharma Chem Technicals

EMA & SMA

Current Price
₹987.15
+ 19.7 (2.04%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹981.62
  • 50 Day
  • ₹1,008.77
  • 100 Day
  • ₹1,066.56
  • 200 Day
  • ₹1,195.36
  • 20 Day
  • ₹978.49
  • 50 Day
  • ₹1,007.70
  • 100 Day
  • ₹1,057.02
  • 200 Day
  • ₹1,203.94

Tatva Chintan Pharma Chem Resistance and Support

PIVOT
₹982.1
Resistance
First Resistance 996.15
Second Resistance 1,005.15
Third Resistance 1,019.20
RSI 50.20
MFI 49.26
MACD Single Line -10.28
MACD -7.07
Support
First Support 973.10
Second Support 959.05
Third Supoort 950.05

Tatva Chintan Pharma Chem Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 47,782 2,175,992 45.54
Week 61,139 3,147,425 51.48
1 Month 62,027 3,261,372 52.58
6 Month 50,201 2,748,484 54.75

Tatva Chintan Pharma Chem Result Highlights

Tatva Chintan Pharma Chem Synopsis

NSE-Chemicals-Basic

Tatva Chintan Pharm is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 378.68 Cr. and Equity Capital is Rs. 23.39 Cr. for the Year ended 31/03/2024. Tatva Chintan Pharma Chem Ltd. is a Public Limited Listed company incorporated on 12/06/1996 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24232GJ1996PLC029894 and registration number is 029894.
Market Cap 2,263
Sales 366
Shares in Float 0.65
No of funds 17
Yield 0.21
Book Value 3.12
U/D Vol ratio 0.7
LTDebt / Equity 1
Alpha -0.26
Beta 0.49

Tatva Chintan Pharma Chem Shareholding Pattern

Owner NameJun-24Mar-24Dec-23Sep-23
Promoters 72.02%72.02%72.02%72.02%
Mutual Funds 10.6%12.84%13.05%13.54%
Insurance Companies 0.11%
Foreign Portfolio Investors 3.37%3.65%4.21%4.4%
Individual Investors 12.43%10.49%9.39%8.72%
Others 1.58%1%1.33%1.21%

Tatva Chintan Pharma Chem Management

Name Designation
Mr. Chintan Nitinkumar Shah Chairman & Managing Director
Mr. Ajaykumar Mansukhlal Patel Whole Time Director
Mr. Shekhar Rasiklal Somani Whole Time Director
Dr. Manher Chimanlal Desai Independent Director
Mr. Subhash Ambubhai Patel Independent Director
Dr. Avani Rajesh Umatt Independent Director

Tatva Chintan Pharma Chem Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Tatva Chintan Pharma Chem Corporate Action

Date Purpose Remarks
2024-07-24 Quarterly Results
2024-05-03 Audited Results & Final Dividend
2024-01-20 Quarterly Results
2023-11-02 Quarterly Results
2023-08-04 Quarterly Results
Date Purpose Remarks
2022-09-09 FINAL Rs.2.00 per share(20%)Final Dividend

Tatva Chintan Pharma Chem FAQs

What is Share Price of Tatva Chintan Pharma Chem ?

Tatva Chintan Pharma Chem share price is ₹987 As on 20 September, 2024 | 18:15

What is the Market Cap of Tatva Chintan Pharma Chem ?

The Market Cap of Tatva Chintan Pharma Chem is ₹2309.2 Cr As on 20 September, 2024 | 18:15

What is the P/E ratio of Tatva Chintan Pharma Chem ?

The P/E ratio of Tatva Chintan Pharma Chem is 88.6 As on 20 September, 2024 | 18:15

What is the PB ratio of Tatva Chintan Pharma Chem ?

The PB ratio of Tatva Chintan Pharma Chem is 3.1 As on 20 September, 2024 | 18:15

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form